Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.
暂无分享,去创建一个
L. Vaca | R. Rossen | D. Mann | T. Yokoyama | W. Durante | P. Hazarika | P. Hazarika
[1] C. Natanson,et al. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. , 1992, The American journal of physiology.
[2] Simon C Watkins,et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.
[3] F. Murad,et al. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. , 1992, Molecular pharmacology.
[4] P. Allen,et al. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. , 1992, Circulation research.
[5] S. Moncada,et al. Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium , 1992, British journal of pharmacology.
[6] B. Parsons,et al. Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.
[7] J. McMurray,et al. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.
[8] E. Arbustini,et al. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. , 1991, The American journal of pathology.
[9] G. Schreiner,et al. A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses. , 1991, Circulation.
[10] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[11] J. Vilček,et al. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. , 1991, The Journal of biological chemistry.
[12] D. Mann,et al. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. , 1991, Circulation research.
[13] J. Larrick,et al. Cytotoxic mechanism of tumor necrosis factor‐α , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] G. Schreiner,et al. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.
[15] H. Fillit,et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.
[16] A. M. Lefer,et al. Mediation of cardioprotection by transforming growth factor-beta. , 1990, Science.
[17] T. Mckenna,et al. Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. , 1990, The Journal of clinical investigation.
[18] J. Adams,et al. hypotension: Implications for the involvement of nitric oxide , 2022 .
[19] O. Nielsen,et al. Recombinant human tumour necrosis factor increases cytosolic free calcium in murine fibroblasts and stimulates inositol phosphate formation in L-M and arachidonic acid release in 3T3 cells. , 1990, Cellular signalling.
[20] G. Schreiner,et al. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Kovacs,et al. The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.
[22] D. Mann,et al. Load Regulation of the Properties of Adult Feline Cardiocytes: Growth Induction by Cellular Deformation , 1989, Circulation research.
[23] C. Natanson,et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock , 1989, The Journal of experimental medicine.
[24] C. Maury,et al. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. , 1989, Journal of internal medicine.
[25] S. Houser,et al. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. , 1988, The American journal of physiology.
[26] D. Kufe,et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. , 1988, Journal of the National Cancer Institute.
[27] Harold V. Gaskill. Continuous infusion of tumor necrosis factor: mechanisms of toxicity in the rat. , 1988, The Journal of surgical research.
[28] P. J. Simpson,et al. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. , 1988, Journal of molecular and cellular cardiology.
[29] K. Spitzer,et al. A video system for measuring motion in contracting heart cells , 1988, IEEE Transactions on Biomedical Engineering.
[30] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[31] D. Newell,et al. In pursuit of evidence based integrated care , 1987, British Journal of Cancer.
[32] C. Herzog,et al. [Interleukin 1 and tumor necrosis factor]. , 1987, Zeitschrift fur Rheumatologie.
[33] M. Rosenblum,et al. Phase I study of recombinant tumor necrosis factor in cancer patients. , 1987, Cancer research.
[34] D. Remick,et al. Acute in vivo effects of human recombinant tumor necrosis factor. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[35] W. Fiers,et al. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. D. Albert,et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. , 1987, Surgery, gynecology & obstetrics.
[37] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[38] H M Piper,et al. Cell cultures of adult cardiomyocytes as models of the myocardium. , 1986, Journal of molecular and cellular cardiology.
[39] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[40] S. Houser,et al. Transmembrane potassium fluxes in isolated feline ventricular myocytes. , 1985, The American journal of physiology.
[41] D. Goeddel,et al. Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.
[42] W. Claycomb. Cardiac muscle cell proliferation and cell differentiation in vivo and in vitro. , 1983, Advances in experimental medicine and biology.
[43] E Neher,et al. A patch‐clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. , 1982, The Journal of physiology.
[44] W. Claycomb,et al. Ultrastructure of terminally differentiated adult rat cardiac muscle cells in culture. , 1982, The American journal of anatomy.
[45] N. Blin,et al. A general method for isolation of high molecular weight DNA from eukaryotes. , 1976, Nucleic acids research.
[46] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.